Royal Bank of Canada’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-459,299
| Closed | -$547K | – | 7501 |
|
|
2022
Q3 | $547K | Buy |
459,299
+17,574
| +4% | +$20.9K | ﹤0.01% | 3516 |
|
|
2022
Q2 | $796K | Sell |
441,725
-39,580
| -8% | -$71.3K | ﹤0.01% | 3287 |
|
|
2022
Q1 | $973K | Sell |
481,305
-17,502
| -4% | -$35.4K | ﹤0.01% | 3235 |
|
|
2021
Q4 | $1.35M | Buy |
498,807
+109,076
| +28% | +$296K | ﹤0.01% | 3066 |
|
|
2021
Q3 | $1.74M | Buy |
389,731
+52,237
| +15% | +$233K | ﹤0.01% | 2783 |
|
|
2021
Q2 | $1.96M | Buy |
337,494
+109,849
| +48% | +$637K | ﹤0.01% | 2732 |
|
|
2021
Q1 | $1.6M | Sell |
227,645
-1,395
| -0.6% | -$9.79K | ﹤0.01% | 2803 |
|
|
2020
Q4 | $1.1M | Sell |
229,040
-31,601
| -12% | -$152K | ﹤0.01% | 2958 |
|
|
2020
Q3 | $1.52M | Buy |
260,641
+35,471
| +16% | +$207K | ﹤0.01% | 2544 |
|
|
2020
Q2 | $1.52M | Buy |
225,170
+210,807
| +1,468% | +$1.42M | ﹤0.01% | 2481 |
|
|
2020
Q1 | $91K | Sell |
14,363
-14,715
| -51% | -$93.2K | ﹤0.01% | 4349 |
|
|
2019
Q4 | $303K | Sell |
29,078
-13,180
| -31% | -$137K | ﹤0.01% | 3760 |
|
|
2019
Q3 | $166K | Buy |
42,258
+3,352
| +9% | +$13.2K | ﹤0.01% | 3998 |
|
|
2019
Q2 | $578K | Buy |
38,906
+6,988
| +22% | +$104K | ﹤0.01% | 3242 |
|
|
2019
Q1 | $793K | Buy |
31,918
+6,222
| +24% | +$155K | ﹤0.01% | 2893 |
|
|
2018
Q4 | $462K | Buy |
25,696
+15,073
| +142% | +$271K | ﹤0.01% | 3198 |
|
|
2018
Q3 | $312K | Sell |
10,623
-116,140
| -92% | -$3.41M | ﹤0.01% | 3647 |
|
|
2018
Q2 | $5.77M | Sell |
126,763
-57,765
| -31% | -$2.63M | ﹤0.01% | 1593 |
|
|
2018
Q1 | $9.74M | Buy |
184,528
+105,584
| +134% | +$5.57M | ﹤0.01% | 1322 |
|
|
2017
Q4 | $5.37M | Sell |
78,944
-3,568
| -4% | -$243K | ﹤0.01% | 1637 |
|
|
2017
Q3 | $6.8M | Buy |
82,512
+22,818
| +38% | +$1.88M | ﹤0.01% | 1466 |
|
|
2017
Q2 | $5.59M | Buy |
59,694
+58,303
| +4,191% | +$5.46M | ﹤0.01% | 1521 |
|
|
2017
Q1 | $88K | Buy |
1,391
+172
| +14% | +$10.9K | ﹤0.01% | 4182 |
|
|
2016
Q4 | $53K | Sell |
1,219
-225,714
| -99% | -$9.81M | ﹤0.01% | 4478 |
|
|
2016
Q3 | $8.18M | Buy |
226,933
+208,721
| +1,146% | +$7.52M | ﹤0.01% | 1329 |
|
|
2016
Q2 | $250K | Buy |
18,212
+17,375
| +2,076% | +$239K | ﹤0.01% | 3589 |
|
|
2016
Q1 | $17K | Sell |
837
-70
| -8% | -$1.42K | ﹤0.01% | 4861 |
|
|
2015
Q4 | $33K | Sell |
907
-12,700
| -93% | -$462K | ﹤0.01% | 4769 |
|
|
2015
Q3 | $1.25M | Buy |
13,607
+5,557
| +69% | +$511K | ﹤0.01% | 2218 |
|
|
2015
Q2 | $708K | Sell |
8,050
-7,850
| -49% | -$690K | ﹤0.01% | 2807 |
|
|
2015
Q1 | $1.18M | Buy |
15,900
+7,363
| +86% | +$546K | ﹤0.01% | 2321 |
|
|
2014
Q4 | $478K | Sell |
8,537
-7,863
| -48% | -$440K | ﹤0.01% | 3084 |
|
|
2014
Q3 | $744K | Buy |
16,400
+8,500
| +108% | +$386K | ﹤0.01% | 2615 |
|
|
2014
Q2 | $327K | Sell |
7,900
-3,500
| -31% | -$145K | ﹤0.01% | 3337 |
|
|
2014
Q1 | $790K | Buy |
11,400
+950
| +9% | +$65.8K | ﹤0.01% | 2550 |
|
|
2013
Q4 | $630K | Buy |
10,450
+9,876
| +1,721% | +$595K | ﹤0.01% | 2692 |
|
|
2013
Q3 | $35K | Buy |
+574
| New | +$35K | ﹤0.01% | 4401 |
|